Market Dynamics
US Avidin market is forecasted to grow at an impressive CAGR of over 6.6% over the 2018 to 2032 period. This growth can be attributed to the growing utilization of avidin products from biotechnological companies and research institutes. Avidin is a poultry-sourced egg white protein often used in molecular biology studies. It binds strongly to biotin, a vitamin found in grains, sunflower seeds, milk, and especially liver. Due to strong affinity towards biotin, it is used as a biotin antagonist, which is beneficial in certain health-related problems. Growing number of biotechnological and health care projects are majorly driving the U.S Avidin market. Majorly, US USDA and FDA regulates the manufacture and sale of all the poultry eggs in the US and the control over the production has further spurred the growth of Avidin market in the US market. Moreover, the use of avidin in molecular biology, is a major factor that is driving the US avidin market growth. As queries and technologies advance in medical fields, the need for specialized proteins, such as avidin, is increasing. Moreover, the technological advancements in molecular biology and biochemistry has enabled synthetics production of avidin proteins.
This has led to the increasing availability of these proteins and increasing their potential applications across various industries. Additionally, the expanding base of biotechnology companies in the US support the research and development of avidin proteins. These companies explore the potential use of these proteins in therapeutic applications and drug delivery. This has further spurred the demand for Avidin proteins in the U.S and would accelerate the growth of the US Avidin market. Thus, rise in the demand of the avidin proteins in the US is expected to fuel the growth of the US market over the forecast period.
